View ValuationSamator Indo Gas 将来の成長Future 基準チェック /36Samator Indo Gasは、35.8%と6.9%でそれぞれ年率35.8%で利益と収益が成長すると予測される一方、EPSはgrowで39.5%年率。主要情報35.8%収益成長率39.53%EPS成長率Chemicals 収益成長-71.3%収益成長率6.9%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日06 Feb 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 06PT Samator Indo Gas Tbk, Annual General Meeting, Jun 11, 2026PT Samator Indo Gas Tbk, Annual General Meeting, Jun 11, 2026. Location: jakarta IndonesiaReported Earnings • May 05First quarter 2026 earnings released: EPS: Rp11.00 (vs Rp2.53 in 1Q 2025)First quarter 2026 results: EPS: Rp11.00 (up from Rp2.53 in 1Q 2025). Revenue: Rp762.1b (up 7.9% from 1Q 2025). Net income: Rp35.2b (up 354% from 1Q 2025). Profit margin: 4.6% (up from 1.1% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in Indonesia. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • Apr 16Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 105% to Rp3,300. The fair value is estimated to be Rp2,702, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Earnings per share has declined by 10%. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 172% in the next 2 years.Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp19.00 (vs Rp34.22 in FY 2024)Full year 2025 results: EPS: Rp19.00 (down from Rp34.22 in FY 2024). Revenue: Rp3.01t (up 3.5% from FY 2024). Net income: Rp58.4b (down 44% from FY 2024). Profit margin: 1.9% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Indonesia. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • Mar 30Now 28% overvalued after recent price riseOver the last 90 days, the stock has risen 124% to Rp3,400. The fair value is estimated to be Rp2,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.2% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 73% in the next 2 years.New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Profit margins are more than 30% lower than last year (2.8% net profit margin).Buy Or Sell Opportunity • Feb 20Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 123% to Rp3,120. The fair value is estimated to be Rp2,508, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.2% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 73% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment improves as stock rises 19%After last week's 19% share price gain to Rp1,950, the stock trades at a trailing P/E ratio of 70.7x. Average trailing P/E is 17x in the Chemicals industry in Indonesia. Negligible returns to shareholders over past three years.Valuation Update With 7 Day Price Move • Nov 26Investor sentiment improves as stock rises 22%After last week's 22% share price gain to Rp1,580, the stock trades at a trailing P/E ratio of 57.3x. Average trailing P/E is 15x in the Chemicals industry in Indonesia. Total loss to shareholders of 29% over the past three years.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 30%After last week's 30% share price gain to Rp1,430, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total loss to shareholders of 34% over the past three years.New Risk • Nov 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indonesian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 5.2% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (2.8% net profit margin).Reported Earnings • Nov 03Third quarter 2025 earnings released: EPS: Rp14.44 (vs Rp4.94 in 3Q 2024)Third quarter 2025 results: EPS: Rp14.44 (up from Rp4.94 in 3Q 2024). Revenue: Rp793.7b (up 7.6% from 3Q 2024). Net income: Rp38.0b (up 151% from 3Q 2024). Profit margin: 4.8% (up from 2.1% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Board Change • Oct 24No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. No independent directors (8 non-independent directors). Independent Commissioner . Robiyanto was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Oct 24Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to Rp1,440, the stock trades at a trailing P/E ratio of 71.6x. Average trailing P/E is 15x in the Chemicals industry in Indonesia. Total loss to shareholders of 26% over the past three years.お知らせ • May 08PT Samator Indo Gas Tbk, Annual General Meeting, Jun 13, 2025PT Samator Indo Gas Tbk, Annual General Meeting, Jun 13, 2025.Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: Rp4.72 (vs Rp14.48 in 3Q 2023)Third quarter 2024 results: EPS: Rp4.72 (down from Rp14.48 in 3Q 2023). Revenue: Rp737.7b (up 1.1% from 3Q 2023). Net income: Rp15.1b (down 66% from 3Q 2023). Profit margin: 2.1% (down from 6.1% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: Rp8.52 (vs Rp8.21 in 2Q 2023)Second quarter 2024 results: EPS: Rp8.52 (up from Rp8.21 in 2Q 2023). Revenue: Rp696.9b (up 5.7% from 2Q 2023). Net income: Rp27.3b (up 8.4% from 2Q 2023). Profit margin: 3.9% (up from 3.8% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • May 19PT Samator Indo Gas Tbk, Annual General Meeting, Jun 24, 2024PT Samator Indo Gas Tbk, Annual General Meeting, Jun 24, 2024. Location: jakarta IndonesiaReported Earnings • May 12Full year 2023 earnings released: EPS: Rp54.01 (vs Rp32.64 in FY 2022)Full year 2023 results: EPS: Rp54.01 (up from Rp32.64 in FY 2022). Revenue: Rp2.82t (up 8.0% from FY 2022). Net income: Rp165.4b (up 67% from FY 2022). Profit margin: 5.9% (up from 3.8% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Recent Insider Transactions • Dec 01Bulk & Onsite Director and Director recently sold Rp37m worth of stockOn the 24th of November, Budi Susanto sold around 25k shares on-market at roughly Rp1,465 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: Rp14.18 (vs Rp6.50 in 3Q 2022)Third quarter 2023 results: EPS: Rp14.18 (up from Rp6.50 in 3Q 2022). Revenue: Rp729.9b (up 15% from 3Q 2022). Net income: Rp44.4b (up 124% from 3Q 2022). Profit margin: 6.1% (up from 3.1% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings.Reported Earnings • Aug 05Second quarter 2023 earnings released: EPS: Rp8.21 (vs Rp2.03 in 2Q 2022)Second quarter 2023 results: EPS: Rp8.21 (up from Rp2.03 in 2Q 2022). Revenue: Rp659.2b (up 13% from 2Q 2022). Net income: Rp25.2b (up 307% from 2Q 2022). Profit margin: 3.8% (up from 1.1% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Apr 07Full year 2022 earnings released: EPS: Rp32.63 (vs Rp66.90 in FY 2021)Full year 2022 results: EPS: Rp32.63 (down from Rp66.90 in FY 2021). Revenue: Rp2.61t (down 4.6% from FY 2021). Net income: Rp99.3b (down 51% from FY 2021). Profit margin: 3.8% (down from 7.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Dec 02Third quarter 2022 earnings released: EPS: Rp6.50 (vs Rp25.51 in 3Q 2021)Third quarter 2022 results: EPS: Rp6.50 (down from Rp25.51 in 3Q 2021). Revenue: Rp636.1b (down 18% from 3Q 2021). Net income: Rp19.8b (down 75% from 3Q 2021). Profit margin: 3.1% (down from 10.0% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Commissioner Agoest Soebhektie was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Oct 21Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to Rp1,910, the stock trades at a trailing P/E ratio of 36.4x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 220% over the past three years.Valuation Update With 7 Day Price Move • Sep 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp2,520, the stock trades at a trailing P/E ratio of 48x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 309% over the past three years.Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: Rp2.03 (vs Rp14.96 in 2Q 2021)Second quarter 2022 results: EPS: Rp2.03 (down from Rp14.96 in 2Q 2021). Revenue: Rp583.8b (down 11% from 2Q 2021). Net income: Rp6.18b (down 86% from 2Q 2021). Profit margin: 1.1% (down from 7.0% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to Rp1,950, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 271% over the past three years.Reported Earnings • May 23First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: Rp14.60 (down from Rp16.22 in 1Q 2021). Revenue: Rp682.6b (up 6.2% from 1Q 2021). Net income: Rp44.4b (down 10.0% from 1Q 2021). Profit margin: 6.5% (down from 7.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Commissioner Agoest Soebhektie was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improved over the past weekAfter last week's 24% share price gain to Rp2,450, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 22x in the Chemicals industry in Indonesia. Total returns to shareholders of 358% over the past three years.Reported Earnings • Apr 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: Rp66.90 (up from Rp31.59 in FY 2020). Revenue: Rp2.74t (up 25% from FY 2020). Net income: Rp204.2b (up 112% from FY 2020). Profit margin: 7.5% (up from 4.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp1,645, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 22x in the Chemicals industry in Indonesia. Total returns to shareholders of 199% over the past three years.Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp1,725, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 38x in the Chemicals industry in Indonesia. Total returns to shareholders of 172% over the past three years.Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS Rp25.50 (vs Rp4.28 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp778.8b (up 43% from 3Q 2020). Net income: Rp77.6b (up Rp64.8b from 3Q 2020). Profit margin: 10.0% (up from 2.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improved over the past weekAfter last week's 18% share price gain to Rp1,600, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 158% over the past three years.Reported Earnings • Aug 31Second quarter 2021 earnings released: EPS Rp14.79 (vs Rp0.74 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: Rp653.1b (up 34% from 2Q 2020). Net income: Rp45.5b (up Rp47.8b from 2Q 2020). Profit margin: 7.0% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Aug 10Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to Rp1,460, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 156% over the past three years.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 26% share price gain to Rp1,340, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 118% over the past three years.Reported Earnings • May 09First quarter 2021 earnings released: EPS Rp16.22 (vs Rp6.19 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: Rp642.7b (up 18% from 1Q 2020). Net income: Rp49.4b (up 160% from 1Q 2020). Profit margin: 7.7% (up from 3.5% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Apr 11Full year 2020 earnings released: EPS Rp31.59 (vs Rp32.93 in FY 2019)The company reported a poor full year result with weaker earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: Rp2.19t (flat on FY 2019). Net income: Rp96.4b (down 4.5% from FY 2019). Profit margin: 4.4% (down from 4.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to Rp1,040, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in Asia. Total returns to shareholders of 47% over the past three years.Valuation Update With 7 Day Price Move • Feb 20Investor sentiment improved over the past weekAfter last week's 18% share price gain to Rp1,465, the stock is trading at a trailing P/E ratio of 78.3x, up from the previous P/E ratio of 66.3x. This compares to an average P/E of 17x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 98%.Valuation Update With 7 Day Price Move • Jan 28Investor sentiment deteriorated over the past weekAfter last week's 25% share price decline to Rp1,395, the stock is trading at a trailing P/E ratio of 74.6x, down from the previous P/E ratio of 99.2x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 75%.Valuation Update With 7 Day Price Move • Jan 11Investor sentiment improved over the past weekAfter last week's 22% share price gain to Rp1,155, the stock is trading at a trailing P/E ratio of 61.8x, up from the previous P/E ratio of 50.5x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 48%.Is New 90 Day High Low • Jan 04New 90-day high: Rp990The company is up 94% from its price of Rp510 on 07 October 2020. The Indonesian market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.Reported Earnings • Dec 04Third quarter 2020 earnings released: EPS Rp4.28The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: Rp546.5b (down 3.3% from 3Q 2019). Net income: Rp12.8b (down 56% from 3Q 2019). Profit margin: 2.3% (down from 5.2% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 25% share price gain to Rp930, the stock is trading at a trailing P/E ratio of 38.7x, up from the previous P/E ratio of 31x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 51%.Valuation Update With 7 Day Price Move • Nov 05Market bids up stock over the past weekAfter last week's 16% share price gain to Rp750, the stock is trading at a trailing P/E ratio of 31.2x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 26%.Valuation Update With 7 Day Price Move • Nov 03Market bids up stock over the past weekAfter last week's 18% share price gain to Rp760, the stock is trading at a trailing P/E ratio of 31.6x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 27%.Is New 90 Day High Low • Nov 02New 90-day high: Rp695The company is up 28% from its price of Rp545 on 04 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.Valuation Update With 7 Day Price Move • Oct 15Market bids up stock over the past weekAfter last week's 18% share price gain to Rp590, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.8x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 3.3%.Is New 90 Day High Low • Oct 15New 90-day high: Rp590The company is up 4.0% from its price of Rp570 on 17 July 2020. The Indonesian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 8.0% over the same period.業績と収益の成長予測IDX:AGII - アナリストの将来予測と過去の財務データ ( )IDR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20283,710,000N/AN/AN/A112/31/20273,462,000159,000595,000538,000112/31/20263,258,000109,000545,000513,00013/31/20263,064,69285,81784,239471,505N/A12/31/20253,008,80358,37924,110451,376N/A9/30/20252,992,66984,583-61,066394,592N/A3/31/20252,922,37674,154-204,322266,033N/A12/31/20242,907,675104,947-311,830273,248N/A9/30/20242,881,286135,408-29,637562,823N/A6/30/20242,873,445164,67350,003660,602N/A3/31/20242,835,869161,98561,880615,072N/A12/31/20232,822,745165,413268,589659,194N/A9/30/20232,777,701128,971104,111486,720N/A6/30/20232,683,892104,354163,165476,384N/A3/31/20232,608,32885,941245,698550,700N/A12/31/20222,612,46488,382182,195522,607N/A9/30/20222,566,679102,047261,966544,684N/A6/30/20222,709,386159,897173,977465,514N/A3/31/20222,778,684199,241195,730500,285N/A12/31/20212,738,813204,183-343,870605,946N/A9/30/20212,686,008239,412-421,771538,090N/A6/30/20212,453,768174,601-359,955588,686N/A3/31/20212,286,446126,806-450,098492,653N/A12/31/20202,188,17996,41292,698364,251N/A9/30/20202,162,67057,02675,607429,771N/A6/30/20202,181,31273,65921,772385,754N/A3/31/20202,225,70289,963-5,623368,998N/A12/31/20192,203,617100,971N/A411,801N/A9/30/20192,227,50199,988N/A440,235N/A6/30/20192,181,051103,345N/A282,790N/A3/31/20192,105,964103,431N/A345,537N/A12/31/20182,073,25899,732N/A311,207N/A9/30/20181,969,97291,893N/A193,603N/A6/30/20181,915,75588,051N/A298,766N/A3/31/20181,896,13288,563N/A246,191N/A12/31/20171,838,41785,569N/A213,726N/A9/30/20171,787,15079,269N/A176,015N/A6/30/20171,703,29758,465N/A167,900N/A3/31/20171,693,69160,580N/A161,033N/A12/31/20161,651,13654,890N/A129,110N/A9/30/20161,624,03047,164N/A-24,200N/A6/30/20161,590,21950,859N/A45,285N/A3/31/20161,513,08643,366N/A7,630N/A12/31/20151,426,44142,260N/A3,285N/A9/30/20151,286,29846,698N/A39,568N/A6/30/20151,237,20535,478N/A4,005N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: AGIIの予測収益成長率 (年間35.8% ) は 貯蓄率 ( 6.7% ) を上回っています。収益対市場: AGIIの収益 ( 35.8% ) はID市場 ( 12.5% ) よりも速いペースで成長すると予測されています。高成長収益: AGIIの収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: AGIIの収益 ( 6.9% ) ID市場 ( 13.7% ) よりも低い成長が予測されています。高い収益成長: AGIIの収益 ( 6.9% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: AGIIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/29 06:36終値2026/05/29 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PT Samator Indo Gas Tbk 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関William SimadiputraDBS Bank LtdTarra LaurentiaPT BNI SecuritiesSyaiful AdrianPT Ciptadana Securities1 その他のアナリストを表示
お知らせ • May 06PT Samator Indo Gas Tbk, Annual General Meeting, Jun 11, 2026PT Samator Indo Gas Tbk, Annual General Meeting, Jun 11, 2026. Location: jakarta Indonesia
Reported Earnings • May 05First quarter 2026 earnings released: EPS: Rp11.00 (vs Rp2.53 in 1Q 2025)First quarter 2026 results: EPS: Rp11.00 (up from Rp2.53 in 1Q 2025). Revenue: Rp762.1b (up 7.9% from 1Q 2025). Net income: Rp35.2b (up 354% from 1Q 2025). Profit margin: 4.6% (up from 1.1% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in Indonesia. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • Apr 16Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 105% to Rp3,300. The fair value is estimated to be Rp2,702, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Earnings per share has declined by 10%. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 172% in the next 2 years.
Reported Earnings • Apr 02Full year 2025 earnings released: EPS: Rp19.00 (vs Rp34.22 in FY 2024)Full year 2025 results: EPS: Rp19.00 (down from Rp34.22 in FY 2024). Revenue: Rp3.01t (up 3.5% from FY 2024). Net income: Rp58.4b (down 44% from FY 2024). Profit margin: 1.9% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Indonesia. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • Mar 30Now 28% overvalued after recent price riseOver the last 90 days, the stock has risen 124% to Rp3,400. The fair value is estimated to be Rp2,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.2% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 73% in the next 2 years.
New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Profit margins are more than 30% lower than last year (2.8% net profit margin).
Buy Or Sell Opportunity • Feb 20Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 123% to Rp3,120. The fair value is estimated to be Rp2,508, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.2% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 73% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment improves as stock rises 19%After last week's 19% share price gain to Rp1,950, the stock trades at a trailing P/E ratio of 70.7x. Average trailing P/E is 17x in the Chemicals industry in Indonesia. Negligible returns to shareholders over past three years.
Valuation Update With 7 Day Price Move • Nov 26Investor sentiment improves as stock rises 22%After last week's 22% share price gain to Rp1,580, the stock trades at a trailing P/E ratio of 57.3x. Average trailing P/E is 15x in the Chemicals industry in Indonesia. Total loss to shareholders of 29% over the past three years.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 30%After last week's 30% share price gain to Rp1,430, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total loss to shareholders of 34% over the past three years.
New Risk • Nov 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indonesian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 5.2% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (2.8% net profit margin).
Reported Earnings • Nov 03Third quarter 2025 earnings released: EPS: Rp14.44 (vs Rp4.94 in 3Q 2024)Third quarter 2025 results: EPS: Rp14.44 (up from Rp4.94 in 3Q 2024). Revenue: Rp793.7b (up 7.6% from 3Q 2024). Net income: Rp38.0b (up 151% from 3Q 2024). Profit margin: 4.8% (up from 2.1% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Board Change • Oct 24No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. No independent directors (8 non-independent directors). Independent Commissioner . Robiyanto was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Oct 24Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to Rp1,440, the stock trades at a trailing P/E ratio of 71.6x. Average trailing P/E is 15x in the Chemicals industry in Indonesia. Total loss to shareholders of 26% over the past three years.
お知らせ • May 08PT Samator Indo Gas Tbk, Annual General Meeting, Jun 13, 2025PT Samator Indo Gas Tbk, Annual General Meeting, Jun 13, 2025.
Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: Rp4.72 (vs Rp14.48 in 3Q 2023)Third quarter 2024 results: EPS: Rp4.72 (down from Rp14.48 in 3Q 2023). Revenue: Rp737.7b (up 1.1% from 3Q 2023). Net income: Rp15.1b (down 66% from 3Q 2023). Profit margin: 2.1% (down from 6.1% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: Rp8.52 (vs Rp8.21 in 2Q 2023)Second quarter 2024 results: EPS: Rp8.52 (up from Rp8.21 in 2Q 2023). Revenue: Rp696.9b (up 5.7% from 2Q 2023). Net income: Rp27.3b (up 8.4% from 2Q 2023). Profit margin: 3.9% (up from 3.8% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • May 19PT Samator Indo Gas Tbk, Annual General Meeting, Jun 24, 2024PT Samator Indo Gas Tbk, Annual General Meeting, Jun 24, 2024. Location: jakarta Indonesia
Reported Earnings • May 12Full year 2023 earnings released: EPS: Rp54.01 (vs Rp32.64 in FY 2022)Full year 2023 results: EPS: Rp54.01 (up from Rp32.64 in FY 2022). Revenue: Rp2.82t (up 8.0% from FY 2022). Net income: Rp165.4b (up 67% from FY 2022). Profit margin: 5.9% (up from 3.8% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Dec 01Bulk & Onsite Director and Director recently sold Rp37m worth of stockOn the 24th of November, Budi Susanto sold around 25k shares on-market at roughly Rp1,465 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: Rp14.18 (vs Rp6.50 in 3Q 2022)Third quarter 2023 results: EPS: Rp14.18 (up from Rp6.50 in 3Q 2022). Revenue: Rp729.9b (up 15% from 3Q 2022). Net income: Rp44.4b (up 124% from 3Q 2022). Profit margin: 6.1% (up from 3.1% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 05Second quarter 2023 earnings released: EPS: Rp8.21 (vs Rp2.03 in 2Q 2022)Second quarter 2023 results: EPS: Rp8.21 (up from Rp2.03 in 2Q 2022). Revenue: Rp659.2b (up 13% from 2Q 2022). Net income: Rp25.2b (up 307% from 2Q 2022). Profit margin: 3.8% (up from 1.1% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Apr 07Full year 2022 earnings released: EPS: Rp32.63 (vs Rp66.90 in FY 2021)Full year 2022 results: EPS: Rp32.63 (down from Rp66.90 in FY 2021). Revenue: Rp2.61t (down 4.6% from FY 2021). Net income: Rp99.3b (down 51% from FY 2021). Profit margin: 3.8% (down from 7.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Dec 02Third quarter 2022 earnings released: EPS: Rp6.50 (vs Rp25.51 in 3Q 2021)Third quarter 2022 results: EPS: Rp6.50 (down from Rp25.51 in 3Q 2021). Revenue: Rp636.1b (down 18% from 3Q 2021). Net income: Rp19.8b (down 75% from 3Q 2021). Profit margin: 3.1% (down from 10.0% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Commissioner Agoest Soebhektie was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Oct 21Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to Rp1,910, the stock trades at a trailing P/E ratio of 36.4x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 220% over the past three years.
Valuation Update With 7 Day Price Move • Sep 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp2,520, the stock trades at a trailing P/E ratio of 48x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 309% over the past three years.
Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: Rp2.03 (vs Rp14.96 in 2Q 2021)Second quarter 2022 results: EPS: Rp2.03 (down from Rp14.96 in 2Q 2021). Revenue: Rp583.8b (down 11% from 2Q 2021). Net income: Rp6.18b (down 86% from 2Q 2021). Profit margin: 1.1% (down from 7.0% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to Rp1,950, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 271% over the past three years.
Reported Earnings • May 23First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: Rp14.60 (down from Rp16.22 in 1Q 2021). Revenue: Rp682.6b (up 6.2% from 1Q 2021). Net income: Rp44.4b (down 10.0% from 1Q 2021). Profit margin: 6.5% (down from 7.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Commissioner Agoest Soebhektie was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improved over the past weekAfter last week's 24% share price gain to Rp2,450, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 22x in the Chemicals industry in Indonesia. Total returns to shareholders of 358% over the past three years.
Reported Earnings • Apr 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: Rp66.90 (up from Rp31.59 in FY 2020). Revenue: Rp2.74t (up 25% from FY 2020). Net income: Rp204.2b (up 112% from FY 2020). Profit margin: 7.5% (up from 4.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to Rp1,645, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 22x in the Chemicals industry in Indonesia. Total returns to shareholders of 199% over the past three years.
Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improved over the past weekAfter last week's 17% share price gain to Rp1,725, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 38x in the Chemicals industry in Indonesia. Total returns to shareholders of 172% over the past three years.
Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS Rp25.50 (vs Rp4.28 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp778.8b (up 43% from 3Q 2020). Net income: Rp77.6b (up Rp64.8b from 3Q 2020). Profit margin: 10.0% (up from 2.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improved over the past weekAfter last week's 18% share price gain to Rp1,600, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 158% over the past three years.
Reported Earnings • Aug 31Second quarter 2021 earnings released: EPS Rp14.79 (vs Rp0.74 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: Rp653.1b (up 34% from 2Q 2020). Net income: Rp45.5b (up Rp47.8b from 2Q 2020). Profit margin: 7.0% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Aug 10Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to Rp1,460, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 156% over the past three years.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 26% share price gain to Rp1,340, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 118% over the past three years.
Reported Earnings • May 09First quarter 2021 earnings released: EPS Rp16.22 (vs Rp6.19 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: Rp642.7b (up 18% from 1Q 2020). Net income: Rp49.4b (up 160% from 1Q 2020). Profit margin: 7.7% (up from 3.5% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Apr 11Full year 2020 earnings released: EPS Rp31.59 (vs Rp32.93 in FY 2019)The company reported a poor full year result with weaker earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: Rp2.19t (flat on FY 2019). Net income: Rp96.4b (down 4.5% from FY 2019). Profit margin: 4.4% (down from 4.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to Rp1,040, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in Asia. Total returns to shareholders of 47% over the past three years.
Valuation Update With 7 Day Price Move • Feb 20Investor sentiment improved over the past weekAfter last week's 18% share price gain to Rp1,465, the stock is trading at a trailing P/E ratio of 78.3x, up from the previous P/E ratio of 66.3x. This compares to an average P/E of 17x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 98%.
Valuation Update With 7 Day Price Move • Jan 28Investor sentiment deteriorated over the past weekAfter last week's 25% share price decline to Rp1,395, the stock is trading at a trailing P/E ratio of 74.6x, down from the previous P/E ratio of 99.2x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 75%.
Valuation Update With 7 Day Price Move • Jan 11Investor sentiment improved over the past weekAfter last week's 22% share price gain to Rp1,155, the stock is trading at a trailing P/E ratio of 61.8x, up from the previous P/E ratio of 50.5x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 48%.
Is New 90 Day High Low • Jan 04New 90-day high: Rp990The company is up 94% from its price of Rp510 on 07 October 2020. The Indonesian market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.
Reported Earnings • Dec 04Third quarter 2020 earnings released: EPS Rp4.28The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: Rp546.5b (down 3.3% from 3Q 2019). Net income: Rp12.8b (down 56% from 3Q 2019). Profit margin: 2.3% (down from 5.2% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 25% share price gain to Rp930, the stock is trading at a trailing P/E ratio of 38.7x, up from the previous P/E ratio of 31x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 51%.
Valuation Update With 7 Day Price Move • Nov 05Market bids up stock over the past weekAfter last week's 16% share price gain to Rp750, the stock is trading at a trailing P/E ratio of 31.2x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 26%.
Valuation Update With 7 Day Price Move • Nov 03Market bids up stock over the past weekAfter last week's 18% share price gain to Rp760, the stock is trading at a trailing P/E ratio of 31.6x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 27%.
Is New 90 Day High Low • Nov 02New 90-day high: Rp695The company is up 28% from its price of Rp545 on 04 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.
Valuation Update With 7 Day Price Move • Oct 15Market bids up stock over the past weekAfter last week's 18% share price gain to Rp590, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.8x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 3.3%.
Is New 90 Day High Low • Oct 15New 90-day high: Rp590The company is up 4.0% from its price of Rp570 on 17 July 2020. The Indonesian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 8.0% over the same period.